NSE
Medplus Health Services LimitedMEDPLUS
Medplus Health Services Limited is a leading healthcare services provider in India, offering a wide range of diagnostic and health check-up services.
| Key products | Diagnostic services, health check-ups |
|---|---|
| Geography | India (primarily in major cities) |
| Competitors | Labcorp Diagnostics India, Apollo Diagnostic Centres |
AI-generated overview — verify before relying on it.
Net institutional flow
−₹785.3 Cr
Institutional buyers
14 in / 4 out
High-impact filings
0 · tilt Neutral
Next corporate action
—
| # | Company | Inst. flow ₹Cr | Deals | Hi-impact | Filing mom. | Buzz | News |
|---|---|---|---|---|---|---|---|
| 1 | ATALREAL | +₹13.1 Cr | 272 | — | — | — | — |
| 2 | MOBIKWIK | +₹5.2 Cr | 355 | — | — | — | — |
| 3 | MTNL | +₹0.1 Cr | 26 | — | — | — | — |
| 4 | MEDPLUSThis | +₹0 Cr | 2 | — | — | — | — |
| 5 | GATECH | −₹0.3 Cr | 77 | — | — | — | — |
| 6 | IRMENERGY | −₹2.2 Cr | 356 | — | — | — | — |
| 7 | QUADFUTURE | −₹7.9 Cr | 177 | — | — | — | — |
Ranked by net institutional flow (buys − sells, ₹Cr). Filing momentum = bullish − bearish filings; Buzz = news+social sentiment. Curate peers in the company admin.
- 2026-06-10FilingIntimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements)Regulations, 2015 Management
- 2026-06-10FilingUpdate under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and DisclosureGeneral
- 2025-11-03BulkSELL · ₹56.4 CrGRAVITON RESEARCH CAPITAL LLP
- 2025-11-03BulkBUY · ₹56.4 CrGRAVITON RESEARCH CAPITAL LLP
- 2025-11-03NetDay net −₹0 Cr
Merged from deals, filings, corporate actions and news — newest first. Compact rolls each day up to net flow + counts. Scope with the range above.
Filings that matter
- 2ManagementNeutral
Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements)Regulations, 2015 regarding Completion of tenure of Mr.
Source PDF → - 2GeneralNeutral
Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Source PDF →
2 deals · 2025-11-03 → 2025-11-03
| Date | Counterparty | Type | Side | Value |
|---|---|---|---|---|
| 2025-11-03 | GRAVITON RESEARCH CAPITAL LLP | Prop / churn | SELL | ₹56.4 Cr |
| 2025-11-03 | GRAVITON RESEARCH CAPITAL LLP | Prop / churn | BUY | ₹56.4 Cr |
2 deals in the selected window — corporate actions are scoped to the same period. ~2 years of history available.
News & chatter on MEDPLUS
RSS News
0No recent news.
Google News RSS — links open the source.
Investdesk
0No articles yet.
Our coverage.
No Reddit chatter.
r/ posts mentioning the company.
Twitter / X
0No posts.
Posts mentioning the company.